NCT00261027View on ClinicalTrials.gov

Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

July 31, 2007

Study Completion Date

September 30, 2007

Conditions
Ovarian Cancer
Interventions
DRUG

Exemestane

Trial Locations (1)

k1h 8l6

Ottawa Regional Cancer Center, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER